Le Bonheur Children’s Heart Institute offers the most advanced treatment options for children, adolescents and adults with complex and uncorrectable congenital or acquired heart disease, including cardiomyopathy.
Heart failure is a term that means the heart does not sufficiently pump enough blood throughout the body. Treatment can vary from medication to the implantation of devices, like a ventricular assist device (VAD), and heart transplantation.
Why Le Bonheur Children’s?
- Our Heart Transplant program, led by Medical Director Jeffrey Towbin, MD, and Surgical Director Umar Boston, MD, is approved by the United Network for Organ Sharing (UNOS).
- Our Heart Institute received the highest quality rating of three stars from The Society of Thoracic Surgery (STS). The three-star rating is awarded for excellence in cardiac surgery outcomes in a four-year period.
- The average survival rates for the majority of heart surgeries at Le Bonheur are considerably higher than the national average.
The program offers individualized care by a multidisciplinary team that includes:
- pediatric cardiologists
- pediatric cardiovascular surgeons
- cardiac intensivists
- specialists in cardiac MRI, ECHO and catheterization
- nurse practitioners and nurses
We are committed to finding new and better ways to treat children with uncorrectable congenital heart disease. Research focuses include:
- Genetic testing and gene discovery
Our researchers are working to discover more about the mechanisms and genes responsible for cardiomyopathy and other causes of heart failure in children.
- Future treatments in children with cardiomyopathy and heart failure
We are working to learn more about transplant rejection and viral causes of myocarditis, cardiomyopathies and transplant coronary disease.